US pharmacy pricing
Where to Find the Cheapest Trazimera Price
Lowest price found · US pharmacies
$3,174.27/fill
for Trazimera, across the pharmacies in our data
US pharmacy prices — 420mg
| Pharmacy | Discount-card price | Regular cash price | Average retail |
|---|---|---|---|
| $3,174.27Lowest | $3,177.27 | $416.05 | |
| $3,174.27Lowest | $3,177.27 | $416.05 | |
| $3,338.79 | $3,341.79 | $416.05 | |
| $3,360.39 | $3,363.39 | $416.05 | |
| $3,438.77 | $3,441.77 | $416.05 | |
| $3,466.90 | $3,466.90 | $416.05 |
"Discount-card price" reflects a standard prescription discount card, not insurance. Prices change often — confirm at the pharmacy before filling.
Interchangeable forms
Per RxNorm (U.S. National Library of Medicine), these share the same active ingredient and strength as Trazimera.
Frequently asked questions
Is Trazimera (Trazimera) expensive if I don't have insurance?
At the US pharmacies in our data, the lowest listed discount-card price for Trazimera is around $3,174.27. Prices vary by pharmacy, dosage, and pack size, so use the table above to compare specific options near you.
Is a generic version of Trazimera available?
Generic and brand-name pricing for Trazimera is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.
What will I pay for Trazimera with my insurance plan?
The cost of Trazimera with insurance varies widely based on your specific plan's formulary, deductible, and coinsurance. You should contact your insurance provider directly to confirm coverage details and your expected copay. If your plan does not cover Trazimera, or if your out-of-pocket costs are high, you may be able to use a pharmacy discount card to obtain a lower price. Patients with Medicare or Medicaid can also use these savings programs if the medication is not covered by their government plan.
Is there a generic version of Trazimera?
No. Trazimera is a branded biologic drug developed by Pfizer U.S. There is currently no FDA-approved biosimilar equivalent for Trazimera available on the market.